Author Correction: A HIF independent oxygen-sensitive pathway for controlling cholesterol synthesis

Affiliations

• ¹ Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, CB2 0AW, UK.
• ² Ochre-Bio Ltd, Hayakawa Building, Oxford Science Park, Edmund Halley Road, Oxford, OX4 4GB, UK.
• ³ Biosciences Institute, Newcastle University, Herschel Building, Level 6, Brewery Lane, Newcastle upon Tyne, NE1 7RU, UK.
• ⁴ Institute for Molecular Systems Biology (IMSB), ETH Zürich, Zürich, Switzerland.
• ⁵ DISCO Pharmaceuticals Swiss GmbH, ETH Zürich, Zürich, Switzerland.
• ⁶ Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ⁷ Tango Therapeutics, 201 Brookline Ave Suite 901, Boston, MA, USA.
• ⁸ Department of Systems Biology, Columbia University, New York, NY, USA.
• ⁹ Department of Biomedical Informatics, Columbia University, New York, NY, USA.
• ¹⁰ Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, CB2 0AW, UK. jan33@cam.ac.uk.